Our analysis suggests that ATP13A3 is a MYC target gene like ODC1 and SLC3A2 and that high expression of ATP13A3 represents an independent prognostic predictor of poor outcome in neuroblastoma. The gene discussed is SLC3A2; the disease is neuroblastoma.